Global GMP Cell Banking Services Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Cell Type;

Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell Type and Others.

By End User;

Biopharmaceutical Companies and Contract Manufacturing Organizations.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn147447584 Published Date: June, 2024 Updated Date: July, 2024


Global GMP Cell Banking Services Market (USD Million), 2020 - 2030

In the year 2023, the Global GMP Cell Banking Services Market was valued at USD 376.32 million. The size of this market is expected to increase to USD 849.22 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 12.3%.

The Global GMP Cell Banking Services Market stands at the forefront of modern biopharmaceutical innovation, serving as a critical pillar in the development and production of advanced therapeutic products. GMP, or Good Manufacturing Practice, is the gold standard for ensuring the quality, safety, and consistency of biologics, necessitating stringent protocols in cell banking. These services play a pivotal role in storing and preserving master cell banks (MCBs) and working cell banks (WCBs), which are essential for the production of biopharmaceuticals, including vaccines, monoclonal antibodies, and cell-based therapies.

Driven by the increasing prevalence of chronic diseases and the burgeoning demand for personalized medicine, the global GMP cell banking services market is witnessing rapid expansion. The rise of regenerative medicine and cell therapy, alongside breakthroughs in biotechnology research, underscores the critical need for reliable and compliant cell banking solutions. As pharmaceutical companies and biotech firms race to bring novel therapies to market, GMP cell banking services emerge as a cornerstone of their development and manufacturing strategies, ensuring product quality and regulatory compliance.

The evolving regulatory landscape, characterized by stringent guidelines and requirements for biologics production, further propels the demand for GMP-compliant cell banking services. Stringent regulatory oversight, particularly in regions like North America and Europe, underscores the imperative for companies to adhere to GMP standards throughout the cell banking process. This regulatory environment, while presenting challenges in compliance and validation, also fosters a culture of quality and safety within the industry, bolstering confidence in biopharmaceutical products.

Looking ahead, the global GMP cell banking services market is poised for sustained growth, fueled by advancements in technology, increasing investment in biotechnology research, and expanding applications in emerging markets. Collaborations between biopharmaceutical companies, research institutions, and service providers are likely to drive innovation and expand service offerings, further solidifying the market's position as a linchpin in the biopharmaceutical value chain. As the quest for novel therapies continues, GMP cell banking services will remain integral, ensuring the reliable supply of high-quality cell lines essential for the development and production of life-saving biologics.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Cell Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global GMP Cell Banking Services Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Biopharmaceutical Industry
        2. Regulatory Requirements and Compliance
        3. Increasing Investment in Biotechnology Research
      2. Restraints
        1. Technical Challenges in Cell Banking
        2. Limited Skilled Workforce
        3. Ethical and Logistical Concerns
      3. Opportunities
        1. Technological Innovations
        2. Increasing Demand for Personalized Medicine
        3. Government Initiatives and Funding
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global GMP Cell Banking Services Market, By Cell Type, 2020- 2030(USD Million)
      1. Mammalian
      2. Microbial
      3. Insect
      4. Yeast
      5. Avian
      6. Stem Cell Type
      7. Others
    2. Global GMP Cell Banking Services Market, By End User, 2020- 2030(USD Million)
      1. Biopharmaceutical Companies
      2. Contract Manufacturing Organizations
    3. Global GMP Cell Banking Services Market, By Geography, 2020- 2030(USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. WuXi AppTec Group
      2. Charles River Laboratories International, Inc
      3. Eurofins Scientific
      4. Merck KGaA
      5. Lonza Group Ltd
      6. SGS Ltd
      7. ViruSure GmbH
      8. Austrianova
  7. Analyst Views
  8. Future Outlook of the Market